$27.79-0.29|(-1.03%)
52W H: 41.1452W L: 10.83Beta: -0.09

About Amylyx Pharmaceuticals Inc

Frequently Asked Questions

What is the 52-week range for AMLX?

The 52-week high is $41.14 and the 52-week low is $10.83.

What is the P/E ratio for AMLX?

The P/E ratio data is currently unavailable.

What is the dividend yield for AMLX?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -52.92%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -94.56%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 4.35.

Analyst Recommendation Trends

Wall Street analyst consensus for AMLX over the last few months:

2026-09-01
Buy: 7
S.Buy: 9
Hold: 2
Sell: 0
2026-08-01
Buy: 7
S.Buy: 8
Hold: 2
Sell: 0
2026-07-01
Buy: 8
S.Buy: 8
Hold: 2
Sell: 0
2026-06-01
Buy: 8
S.Buy: 8
Hold: 2
Sell: 0

Latest AMLX News

Our Pick Of The Best Growth Stocks In September 2026

Bond markets have been shaken by 10-year Treasury yields hitting a 19-year high, which raises borrowing costs and forces investors to rethink where future returns might come from. That kind of reset often shifts attention toward businesses where earnings are expected to grow solidly and balance sheets still look healthy. This article highlights three stocks that fit that profile and explains how they may fit into a long-term growth plan. The three stocks covered next are only a small sample...

Yahoo9/25/2026

Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum

CAMBRIDGE, Mass., September 23, 2026--Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum

Yahoo9/23/2026

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 12:20 PM EDTCompany ParticipantsJoshua Cohen...

SeekingAlpha9/16/2026

Rezolute: Initiating At Sell Despite Attempts To Rescue Ersodetug Following sunRIZE Upset

Phase 3 sunRIZE miss in congenital hyperinsulinism hurts FDA odds; limited upside and high cash burn signal dilution risk. Click for more on RZLT stock.

SeekingAlpha9/10/2026

Tortugas Neuroscience Announces Appointment of Jim Frates to Board of Directors

FRAMINGHAM, Mass., September 09, 2026--Tortugas Neuroscience ("Tortugas"), a clinical-stage central nervous system (CNS)-focused biotech company developing medicines with clinically validated mechanisms of action in indications with both substantial patient populations and high unmet need, today announced the appointment of Jim Frates to its Board of Directors and as Chair of the Audit Committee. A highly experienced biopharmaceutical leader who has served as chief financial officer (CFO) for mu

Yahoo9/9/2026

Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference

CAMBRIDGE, Mass., September 08, 2026--Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference

Yahoo9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to AMLX:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-10Mazzariello Gina-11$33.34$367
2026-09-10Mazzariello Gina-9,525$32.4556$309,140
2026-09-10Cohen Joshua B-919$33.1488$30,464
2026-09-10Cohen Joshua B-29,545$32.1557$950,040
2026-09-10Klee Justin B.-1,439$33.1552$47,710
2026-09-10Klee Justin B.-29,025$32.1293$932,553
2026-09-10Bedrosian Camille L-2,081$33.0919$68,864
2026-09-10Bedrosian Camille L-7,947$32.2139$256,004
2026-09-10FRATES JAMES M-1,042$33.2302$34,626
2026-09-10FRATES JAMES M-9,768$32.2681$315,195
2026-08-31Firestone Karen-25,000--
2026-08-31Firestone Karen-25,000--
2026-08-31Firestone Karen+25,000$5.05$126,250
2026-08-31Firestone Karen+25,000$1.76$44,000
2026-08-18Klee Justin B.+60,039--
2026-08-18Mazzariello Gina+21,284--
2026-08-18Cohen Joshua B+60,039--
2026-08-18Bedrosian Camille L+22,807--
2026-08-18FRATES JAMES M+22,807--
2026-07-10Mazzariello Gina-15,000$17.6081$264,122
2026-07-09Mazzariello Gina-15,000$18.3164$274,746
2026-06-04Zeiher Bernhardt G+24,372--
2026-06-04Firestone Karen+24,372--
2026-06-04FONTEYNE PAUL R.+24,372--
2026-06-04Quimi Daphne+24,372--
2026-06-04MILNE GEORGE M JR+24,372--
2026-05-21Firestone Karen+3,800$13.51$51,338
2026-03-05Cohen Joshua B+373,295--
2026-03-05Cohen Joshua B+248,865--
2026-03-05Mazzariello Gina+111,990--
2026-03-05Mazzariello Gina+74,660--
2026-03-05Klee Justin B.+373,295--
2026-03-05Klee Justin B.+248,865--
2026-03-05Bedrosian Camille L+143,985--
2026-03-05Bedrosian Camille L+95,990--
2026-03-05FRATES JAMES M+143,985--
2026-03-05FRATES JAMES M+95,990--
2026-03-02Klee Justin B.-29,282$14.4717$423,760
2026-03-02Cohen Joshua B-29,282$14.484$424,120
2026-03-02Mazzariello Gina-6,844$14.5205$99,378
2026-03-02Bedrosian Camille L-6,461$14.5806$94,205
2026-03-02FRATES JAMES M-7,909$14.5216$114,851
2026-02-23Mazzariello Gina-3,419$14.1422$48,352
2026-02-02Cohen Joshua B-15,500$14.6834$227,593
2026-02-02Mazzariello Gina-3,448$14.6507$50,516
2026-02-02Klee Justin B.-15,500$14.685$227,618
2026-02-02FRATES JAMES M-3,557$14.6463$52,097
2026-01-16Cohen Joshua B-2,818--
2026-01-16Cohen Joshua B-1,974$13.8293$27,299
2026-01-16Cohen Joshua B+2,818$7.57$21,332
2026-01-16Klee Justin B.-2,847--
2026-01-16Klee Justin B.-1,995$13.8853$27,701
2026-01-16Klee Justin B.+2,847$7.57$21,552
2026-01-15Cohen Joshua B-197,182--
2026-01-15Cohen Joshua B-136,193$13.5895$1,850,795
2026-01-15Cohen Joshua B+197,182$7.57$1,492,668
2026-01-15Klee Justin B.-197,153--
2026-01-15Klee Justin B.-136,193$13.5827$1,849,869
2026-01-15Klee Justin B.+197,153$7.57$1,492,448
2026-01-12MILNE GEORGE M JR-17,780--
2026-01-06Cohen Joshua B-7,715$11.0948$85,596
2026-01-06Klee Justin B.-7,715$11.0939$85,589
2026-01-06FRATES JAMES M-3,326$11.1106$36,954
2025-12-23Firestone Karen+8,100$12.45$100,845
2025-12-01Bedrosian Camille L-6,580$14.3493$94,418